AIMD: Ainos, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.34
Enterprise Value ($M) 19.44
Book Value ($M) 15.52
Book Value / Share 1.01
Price / Book 0.54
NCAV ($M) -8.97
NCAV / Share -0.58
Price / NCAV -0.93

Profitability (mra)
Return on Invested Capital (ROIC) -0.49
Return on Assets (ROA) -0.50
Return on Equity (ROE) -0.66

Liquidity (mrq)
Quick Ratio 1.06
Current Ratio 1.10

Balance Sheet (mrq) ($M)
Current Assets 4.34
Assets 28.82
Liabilities 13.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.02
Operating Income -13.84
Net Income -14.86
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -5.81
Cash from Investing -0.13
Cash from Financing 8.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-11 13D Chun-Hsien Tsai 8.31
04-11 13D Ting Chuan Lee 7.20
04-09 13D/A Ainos Inc 10.68 0.00
03-12 13D/A Advanced Semiconductor Engineering Inc 17.00 36.19
08-21 13D Taiwan Carbon Nano Technology Corp 40.23
05-06 13D/A Amarillo Biosciences Inc 63.36 76.37

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 27,267 88,379 30.85
2025-04-16 37,058 70,332 52.69
2025-04-15 26,821 190,393 14.09

(click for more detail)

Similar Companies
ADTX – Aditxt, Inc. ADVM – Adverum Biotechnologies, Inc.
AGEN – Agenus Inc. AKAN – Akanda Corp.
AKBA – Akebia Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.